Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (5y) (2017 - 2026)
Enanta Pharmaceuticals (ENTA) Cash & Equivalents Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Enanta Pharmaceuticals | 369.97 Mn | 206.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.65% |
| Dec 31, 2025 | -7.44% |
| Sep 30, 2025 | -18.00% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -4.13% |
| Dec 31, 2024 | 25.07% |
| Sep 30, 2024 | -6.18% |
| Jun 30, 2024 | -17.61% |
| Mar 31, 2024 | -9.73% |
| Dec 31, 2023 | -11.69% |
| Sep 30, 2023 | 5.97% |
| Jun 30, 2023 | 17.51% |
| Mar 31, 2023 | 1.80% |
| Dec 31, 2022 | -9.10% |
| Sep 30, 2022 | -7.70% |
| Jun 30, 2022 | 4.97% |
| Mar 31, 2022 | 16.37% |
| Dec 31, 2021 | 36.88% |
| Sep 30, 2021 | 28.11% |
| Jun 30, 2021 | -28.60% |